Canada BC health officials lukewarm on cannabis as harm reduction Amid a grim and growing number of overdose deaths, experts say that evidence is clear and compelling for cannabis as a harm-reduction tool Natalia Buendia CalvilloMarch 5, 2021
Medical and Pharmaceutical LSD could be used to treat people with autism, study suggests Early evidence shows LSD promotes social behaviour in rodents, but pharmaceutical research is still a ways off Natalia Buendia CalvilloMarch 1, 2021
Health and Safety Mexican university launches country’s first international medical cannabis diploma In an effort to educate doctors and improve patient access, Khiron Life Sciences and Tecnológico de Monterrey have teamed up to launch the program Natalia Buendia CalvilloFebruary 24, 2021
Medical and Pharmaceutical Nature amplifies therapeutic effects of psychedelics: study A recent review suggests natural settings and activities can complement all stages of psychedelic-assisted therapy Natalia Buendia CalvilloFebruary 23, 2021
Canada Can patients trust CannTrust’s new medical brand estora? While the company seems sincere in its effort to make amends through a renewed patient focus, not every former client is in a rush... Ashley KeenanFebruary 16, 2021
Analysis Field Trip white paper makes strong health and business case for ketamine therapy With solid efficacy and low cost, the popular club drug could help curb the personal toll and multi-billion dollar cost of North America's battle... Natalia Buendia CalvilloFebruary 9, 2021
Canada Canadian cannabis exports increased nearly 300% in 2020 Led by robust medical markets in Israel and Germany, 13,849 kg of dried flower and 10,494 L of oil was shipped out of country Nick LabaJanuary 29, 2021
Canada Proposed amendment could greatly expand access to psychedelic therapy in Canada Proposed by Health Canada, the change would allow patients to access restricted substances like MDMA through the Special Access Program Natalia Buendia CalvilloJanuary 28, 2021
Canada ‘We are failing patients’: Cannabis Act industry-led review session III Continued stigma and regulatory burdens are causing ongoing accessibility issues for Canadian cannabis patients, group members say Nicholas SokićJanuary 22, 2021
Data Cannabis significantly reduces prescription opioid use: Tilray patient study In the first substitution study to track individual use over time, researchers found stark drops in use of opioids and other medications Nick LabaJanuary 22, 2021